ACROMETA GROUP


Associated tags: Laboratory, Biotechnology, Research, LSI, SME, Executive

Locations: BRISBANE, INDONESIA, FENGLIN, CHINA, SINGAPORE, MA, AUSTRALIA

ACROMETA Acquires Controlling Stake in Co-Working Lab Space Company Life Science Incubator (LSI)

Retrieved on: 
Monday, February 20, 2023

LSI currently operates a 6,500 sq feet co-working laboratory space at The German Centre in Singapore serving SMEs and start-ups.

Key Points: 
  • LSI currently operates a 6,500 sq feet co-working laboratory space at The German Centre in Singapore serving SMEs and start-ups.
  • Launched in September 2021, LSI at German Centre garners very healthy occupancy rates within a year of operations.
  • The additional stake will add another dimension of growth to the Group's business as it becomes not only a builder of laboratories but also an operator of co-working laboratory space.
  • "This potentially carves out a new promising mainstream business for us as controlled environment specialist", says ACROMETA Executive Chairman, Mr Levin Lee Keng Weng.

ACROMETA Group Appoints Veteran Investor Mr. Levin Lee as Executive Chairman

Retrieved on: 
Wednesday, February 1, 2023

SINGAPORE, Feb 1, 2023 - (ACN Newswire) - ACROMETA Group Limited [SGX: 1CH1] today announced that with effect from 30 January 2023, it has appointed Mr Levin Lee Keng Weng as Executive Chairman and Director of the Board.

Key Points: 
  • SINGAPORE, Feb 1, 2023 - (ACN Newswire) - ACROMETA Group Limited [SGX: 1CH1] today announced that with effect from 30 January 2023, it has appointed Mr Levin Lee Keng Weng as Executive Chairman and Director of the Board.
  • On the appointment of Levin as Executive Chairman, ACROMETA Chief Executive Officer and Executive Director Mr Lim Say Chin said, "Levin's experience, business network and financial resources will be beneficial to ACROMETA as we advance to capture growth opportunities in our controlled environments engineering business.
  • Mr Levin Lee said, "SMEs in Singapore with good potential are often neglected by investors who do not understand their business.
  • The appointment of Mr Lee as Executive Chairman is in accordance with corporate governance best practice that the post of Chief Executive Officer should be separate from that of Chairman of the Board.

ACROMETA receives LOA for S$6.1 million design and build works from a global clinical research organisation

Retrieved on: 
Friday, December 30, 2022

The Project site work is commencing soon and a binding contract would be executed in due course.

Key Points: 
  • The Project site work is commencing soon and a binding contract would be executed in due course.
  • In the unlikely event that the execution of contract is not followed through, the Group is safeguarded as it would be entitled to claim a maximum value of approximately S$1.8 million for value of works performed.
  • Said Mr Lim Say Chin, Executive Chairman, "We are greatly encouraged that the Project involves a new customer in the biotechnology space.
  • We will continue to work hard towards delivering quality services, leveraging on our established track record and proven expertise as controlled environment specialist engineers."